These effects, along with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the notion of targeting ACKR3 as a novel technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar Issues.